Mild gastrointestinal effects commonly occur during this period as the body adapts to GLP-1 receptor activation
86 complaints, bundle pricing traps, a no-refund-once-shipped policy, and a cancellation process that requires a phone call with retention scripts
Table of Contents How Retatrutide Works and What Results to Expect Typical Timeline for Weight Loss with Retatrutide Factors That Influence How Quickly You See Changes What the Clinical Trial Evidence Shows When to Speak to Your Doctor About Your Progress Current Availability and Regulatory Status in the UK Scientific References Frequently Asked Questions How Retatrutide Works and What Results to Expect Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, reducing appetite, supporting insulin sensitivity, and potentially increasing energy expenditure
S L-serinamide (L-serine with the carboxylic acid group replaced with a carboxamide)
If FDA approves in 2027, UK availability could come in late 2027 or early 2028
Other Double Agonists and Triple Agonist Beyond tirzepatide, pharmaceutical companies have developed additional dual receptor agonists targeting GLP-1 and glucagon (GCG) as well as triple receptor agonists.210 Mazdutide represents the most recent advancement in GLP-1/GCG dual receptor agonists;211213 this agent, co-developed by Cinda Biology and Lilly Pharmaceutical, received marketing approval in China on June 27, 2025
&srotate=0)
